Erythromycin: safety issues | CMAC

Erythromycin: safety issues

Clinical Microbiology and Antimicrobial Chemotherapy. 2018; 20(3):199-204

Section
Type
Journal article

Abstract

Macrolide antimicrobials are widely used for the treatment of variety of community-acquired bacterial infections. This paper is aimed to review the data on the safety issues of erythromycin. The main attention is paid to the studies on erythromycin prokinetic properties, cardiotoxicity and fetotoxicity.

Views
0 Abstract
0 PDF
0 Crossref citations
Shared